Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 89 articles: HTML format Text format

Single Articles

January 2012
1. DUBSKY PC , Jakesz R, Mlineritsch B, Postlberger S, et al
   Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HURWITZ HI , Lyman GH
   Registries and Randomized Trials in Assessing the Effects of Bevacizumab in Colorectal Cancer: Is There a Common Theme?
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
3. MEYERHARDT JA , Li L, Sanoff HK, Carpenter W 4th, et al
   Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BAE S , Tie J, Desai J, Gibbs P, et al
   Microsatellite Instability Status Is Critical to Analysis of Survival in Stage II Colon Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
5. ADIBE OO , Sharp RJ
   Colon Cancer With Microsatellite Instability in a 13-Year-Old Hispanic Male.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. ROBBINS AS , Siegel RL, Jemal A
   Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. CERCEK A , Saltz L
   Factors Dictating Outcomes in Patients With Colorectal Cancer and Peritoneal Carcinomatosis: Selection, Resection, or Convection?
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. GOVINDARAJAN A , Gonen M, Weiser MR, Shia J, et al
   Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.
   J Clin Oncol. 2011;29:4568-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
9. RAHBARI NN , Bork U, Motschall E, Thorlund K, et al
   Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JEON JY , Meyerhardt JA
    Energy in and Energy out: What Matters for Survivors of Colorectal Cancer?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. CAMPBELL PT , Newton CC, Dehal AN, Jacobs EJ, et al
    Impact of Body Mass Index on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DEHAL AN , Newton CC, Jacobs EJ, Patel AV, et al
    Impact of Diabetes Mellitus and Insulin Use on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. IPACH I , von Weyhern CH, Kopp HG, Kunze B, et al
    Extremity leiomyosarcoma metastasizing to the large bowel as a pedunculated colon polyp.
    J Clin Oncol. 2011;29:e799-802.
    PubMed     Text format     Related articles   
    
    
    
    
14. SANAL SM , Sivrikoz ON, Karapolat I, Karademir S, et al
    Complete clinical response in squamous cell carcinoma of the rectum with liver metastases.
    J Clin Oncol. 2011;29:e806-8.
    PubMed     Text format     Related articles   
    
    
    
    
15. WEISER MR , Gonen M, Chou JF, Kattan MW, et al
    Predicting Survival After Curative Colectomy for Cancer: Individualizing Colon Cancer Staging.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KENNEDY RD , Bylesjo M, Kerr P, Davison T, et al
    Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. GRAY RG , Quirke P, Handley K, Lopatin M, et al
    Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHANG PH , Hung MJ, Yeh KY, Yang SY, et al
    Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.
    J Clin Oncol. 2011;29:e776-8.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
19. GLYNNE-JONES R
    The future of rectal cancer: let's do the right trials.
    J Clin Oncol. 2011;29:4057-9.
    PubMed     Text format     Related articles   
    
    
    
    
20. CHIBAUDEL B , Bonnetain F, Shi Q, Buyse M, et al
    Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to Failure of Strategy--An Aide et Recherche en Cancerologie Digestive Group Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. WEISS JM , Pfau PR, O'Connor ES, King J, et al
    Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare Data.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. BENDELL JC , Nemunaitis J, Vukelja SJ, Hagenstad C, et al
    Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. PATEL UB , Taylor F, Blomqvist L, George C, et al
    Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    J Clin Oncol. 2011;29:3753-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
24. TAKASHIMA M , Kakimoto T, Saito H, Misaki S, et al
    Synchronous Tumor With Diffuse Large B-Cell Lymphoma and Ameboma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. ROTHER MJ
    Survival Benefit From Up-Front Fluorouracil, Leucovorin, and Irinotecan/Cetuximab in Metastatic Colorectal Cancer: Is It Just a Now-or-Never Result?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. SUNESEN KG , Norgaard M, Lundby L, Havsteen H, et al
    Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study.
    J Clin Oncol. 2011;29:3535-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. WRIGHT JD , Neugut AI, Wilde ET, Buono DL, et al
    Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.
    J Clin Oncol. 2011;29:3408-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CREA F , Fornaro L, Masi G, Falcone A, et al
    Faithful markers of circulating cancer stem cells: is CD133 sufficient for validation in clinics?
    J Clin Oncol. 2011;29:3487-8.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
29. MA Y , Zhang P, Wang F, Yang J, et al
    Association Between Vitamin D and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BRENNER H , Chang-Claude J, Seiler CM, Hoffmeister M, et al
    Long-Term Risk of Colorectal Cancer After Negative Colonoscopy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. YOTHERS G , O'Connell MJ, Allegra CJ, Kuebler JP, et al
    Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. RAIMUNDO FV , Faulhaber GA, Furlanetto TW
    Evaluating vitamin D status in ill patients.
    J Clin Oncol. 2011;29:3337-8.
    PubMed     Text format     Related articles   
    
    
    
    
33. VALENTINI V , van Stiphout RG, Lammering G, Gambacorta MA, et al
    Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
    J Clin Oncol. 2011;29:3163-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. NIEDZWIECKI D , Bertagnolli MM, Warren RS, Compton CC, et al
    Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
    J Clin Oncol. 2011;29:3146-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. KAWAKAMI H , Sugioka K, Yonesaka K, Satoh T, et al
    Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis.
    J Clin Oncol. 2011;29:e678-9.
    PubMed     Text format     Related articles   
    
    
    
    
36. TRONCONI MC , Sclafani F, Rimassa L, Carnaghi C, et al
    Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.
    J Clin Oncol. 2011;29:e680-1.
    PubMed     Text format     Related articles   
    
    
    
    
37. FURUYA Y , Wakahara T, Akimoto H, Kishimoto T, et al
    Clear cell adenocarcinoma with enteroblastic differentiation of the ascending colon.
    J Clin Oncol. 2011;29:e647-9.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
38. BESSA X , Alenda C, Paya A, Alvarez C, et al
    Validation Microsatellite Path Score in a Population-Based Cohort of Patients With Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. O'CONNOR ES , Greenblatt DY, Loconte NK, Gangnon RE, et al
    Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MEROPOL NJ
    Ongoing Challenge of Stage II Colon Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. FALTAS B , Zeidan A, Peters K, Das A, et al
    Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
    J Clin Oncol. 2011;29:2946-7.
    PubMed     Text format     Related articles   
    
    
    
    
42. HUBBARD J , Jatoi A
    Adjuvant Chemotherapy in Colon Cancer: Ageism or Appropriate Care?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. JANSEN L , Herrmann A, Stegmaier C, Singer S, et al
    Health-Related Quality of Life During the 10 Years After Diagnosis of Colorectal Cancer: A Population-Based Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ABRAMS TA , Brightly R, Mao J, Kirkner G, et al
    Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. BERTAGNOLLI MM , Redston M, Compton CC, Niedzwiecki D, et al
    Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer--A Study of CALGB 9581 and 89803.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. WEISER MR
    Rectal cancer trials: no movement.
    J Clin Oncol. 2011;29:2746-8.
    PubMed     Text format     Related articles   
    
    
    
    
47. ASCHELE C , Cionini L, Lonardi S, Pinto C, et al
    Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.
    J Clin Oncol. 2011;29:2773-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. ALMAGRO BM , Steyls MC, Navarro NL, Dominguez EG, et al
    Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil.
    J Clin Oncol. 2011;29:e613-5.
    PubMed     Text format     Related articles   
    
    
    
    
49. DEWDNEY A , Hawkes EA, Cunningham D
    Reply to M. Mohiuddin et al.
    J Clin Oncol. 2011;29:2737-8.
    PubMed     Text format     Related articles   
    
    
    
    
50. LINDSKOG DM , Nikkhou K, Talusan P
    False-positive positron emission tomography in patients with history of malignancy.
    J Clin Oncol. 2011;29:e582-5.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
51. NAGTEGAAL ID , Tot T, Jayne DG, McShane P, et al
    Lymph nodes, tumor deposits, and TNM: are we getting better?
    J Clin Oncol. 2011;29:2487-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. PRICE TJ , Hardingham JE, Lee CK, Weickhardt A, et al
    Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. BASS A
    Impact of KRAS and BRAF Gene Mutations on Targeted Therapies in Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
54. BLANKE CD , Bot BM, Thomas DM, Bleyer A, et al
    Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KWON JS , Scott JL, Gilks CB, Daniels MS, et al
    Testing women with endometrial cancer to detect Lynch syndrome.
    J Clin Oncol. 2011;29:2247-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. GLIMELIUS B , Beets-Tan R, Blomqvist L, Brown G, et al
    Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer.
    J Clin Oncol. 2011;29:2142-3.
    PubMed     Text format     Related articles   
    
    
    
    
57. CHAN A , Chiang J, Lew KY, Chay WY, et al
    Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
    J Clin Oncol. 2011;29:e489.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
58. HECHT JR , Trarbach T, Hainsworth JD, Major P, et al
    Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.
    J Clin Oncol. 2011;29:1997-2003.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. VAN CUTSEM E , Bajetta E, Valle J, Kohne CH, et al
    Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinoma.
    J Clin Oncol. 2011;29:2004-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. UENO H , Mochizuki H, Shirouzu K, Kusumi T, et al
    Actual Status of Distribution and Prognostic Impact of Extramural Discontinuous Cancer Spread in Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
61. WICHA MS , Hayes DF
    Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.
    J Clin Oncol. 2011;29:1508-11.
    PubMed     Text format     Related articles   
    
    
    
    
62. RICHMAN SD , Barrett JH, Seymour MT
    Failure to validate toxicity and outcome biomarkers from the FFCD 2000-05 trial in the MRC CR08 FOCUS trial.
    J Clin Oncol. 2011;29:e354-5.
    PubMed     Text format     Related articles   
    
    
    
    
63. MOHIUDDIN M , Mohiuddin MM
    Neoadjuvant chemoradiation in rectal cancer: time to start in a new direction.
    J Clin Oncol. 2011;29:e350-1.
    PubMed     Text format     Related articles   
    
    
    
    
64. VAN CUTSEM E , Kohne CH, Lang I, Folprecht G, et al
    Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. RODRIGUEZ NA , Ascaso FJ
    Trichomegaly and Poliosis of the Eyelashes During Cetuximab Treatment of Metastatic Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. LEIGHL NB , Shepherd HL, Butow PN, Clarke SJ, et al
    Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. SOBRERO AF , Bruzzi P
    Vatalanib in Advanced Colorectal Cancer: Two Studies With Identical Results.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. ARORA NK , Reeve BB, Hays RD, Clauser SB, et al
    Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.
    J Clin Oncol. 2011;29:1280-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
69. NG K , Sargent DJ, Goldberg RM, Meyerhardt JA, et al
    Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. IINUMA H , Watanabe T, Mimori K, Adachi M, et al
    Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. VOSSEN CY , Hoffmeister M, Chang-Claude JC, Rosendaal FR, et al
    Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. GOLLINS S , Sun Myint A, Haylock B, Wise M, et al
    Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    J Clin Oncol. 2011;29:1042-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. BROUQUET A , Abdalla EK, Kopetz S, Garrett CR, et al
    High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
    J Clin Oncol. 2011;29:1083-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. SANTINI D , Galluzzo S, Gaeta L, Zoccoli A, et al
    Should oncologists be aware in their clinical practice of KRAS molecular analysis?
    J Clin Oncol. 2011;29:e206-7.
    PubMed     Text format     Related articles   
    
    
    
    
75. VON DER THUSEN JH , van de Wetering MD, Westermann AM, Heideman DA, et al
    Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.
    J Clin Oncol. 2011;29:e188-90.
    PubMed     Text format     Related articles   
    
    
    
    
76. HALLER DG , Tabernero J, Maroun J, de Braud F, et al
    Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. HUTCHINS G , Southward K, Handley K, Magill L, et al
    Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. TAN BR , Thomas F, Myerson RJ, Zehnbauer B, et al
    Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
    J Clin Oncol. 2011;29:875-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
79. MLECNIK B , Tosolini M, Kirilovsky A, Berger A, et al
    Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    J Clin Oncol. 2011;29:610-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. RENNERT G , Pinchev M, Rennert HS, Gruber SB, et al
    Use of Bisphosphonates and Reduced Risk of Colorectal Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. MOOSMANN N , von Weikersthal LF, Vehling-Kaiser U, Stauch M, et al
    Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
82. BROUSSARD EK , Disis ML
    TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
83. SHACHAM-SHMUELI E , Beny A, Geva R, Blachar A, et al
    Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
84. VAN ENGELAND M , Derks S, Smits KM, Meijer GA, et al
    Colorectal Cancer Epigenetics: Complex Simplicity.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KLOOR M , Voigt AY, Schackert HK, Schirmacher P, et al
    Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
    J Clin Oncol. 2011;29:223-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. DA COSTA AA , Flora AC, Stroher M, Soares FA, et al
    Primary Hodgkin's Lymphoma of the Rectum: An Unusual Presentation.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
87. ALLEGRA CJ , Yothers G, O'Connell MJ, Sharif S, et al
    Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
    J Clin Oncol. 2011;29:11-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
88. JENSEN SA , Hasbak P, Mortensen J, Sorensen JB, et al
    Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
    J Clin Oncol. 2010;28:5280-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
89. SILVESTRIS N , Zito FA, Fiore MG, Simone G, et al
    Synchronous Presentation of B-Cell Chronic Lymphocytic Leukemia/Small-Cell Lymphoma and Colon Adenocarcinoma Within the Same Mesenteric Lymph Nodes and a Single Liver Metastasis.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: